Literature DB >> 3734793

Effects of postdecapitative ischemia on mitochondrial respiration in brain tissue homogenates.

N R Sims, J M Finegan, J P Blass.   

Abstract

Mitochondria isolated from ischemic brain characteristically show changes in respiratory function. As conventional procedures for mitochondrial isolation yield a subpopulation of the total population and require extensive manipulation, it is unclear to what extent these changes are representative of mitochondria in the unfractionated tissue. We previously showed that the oxygen uptake by unfractionated forebrain homogenates, measured under two different sets of incubation conditions, provided information on some aspects of the respiratory activity of both the free and synaptosomal pools of mitochondria. Forebrain homogenates from animals subjected to 30 min of postdecapitative ischemia exhibited large reductions in oxygen uptake rates measured in a high K+ (mitochondrial) buffer in the presence of either ADP (44% of control values) or an uncoupling agent (45% of control values). These reductions in respiratory activity were comparable to alterations observed under the same conditions for mitochondria isolated from the ischemic brains. Similar alterations were seen in homogenates from three subregions: neocortex, hippocampus, and striatum. In a physiological buffer, in which oxygen uptake by homogenates largely resulted from activity of mitochondria within synaptosomes, there was little or no change in basal glucose-supported rates (79-96% of control values) and small reductions in maximal rates (63-81% of control values) measured in the presence of an uncoupling agent. These results suggest that alterations of respiratory function seen in isolated free mitochondria provide appropriate estimates of the dysfunction in the total free mitochondrial pool but that synaptosomal mitochondria may be less affected. Measurements of respiratory function of isolated synaptosomes from ischemic tissue provided further support for the relative preservation of synaptosomal mitochondria during ischemic insult.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734793     DOI: 10.1111/j.1471-4159.1986.tb04530.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  Pyruvate dehydrogenase complex is inhibited in calcium-loaded cerebrocortical mitochondria.

Authors:  J C Lai; J C DiLorenzo; K F Sheu
Journal:  Neurochem Res       Date:  1988-11       Impact factor: 3.996

3.  The mitochondrial permeability transition pore and nitric oxide synthase mediate early mitochondrial depolarization in astrocytes during oxygen-glucose deprivation.

Authors:  S A Reichert; J S Kim-Han; L L Dugan
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

Review 4.  Energy metabolism and selective neuronal vulnerability following global cerebral ischemia.

Authors:  N R Sims
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 5.  Astrocyte mitochondria in in vitro models of ischemia.

Authors:  Laura L Dugan; Jeong-Sook Kim-Han
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 6.  Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia.

Authors:  Kiran S Panickar; Richard A Anderson
Journal:  Int J Mol Sci       Date:  2011-11-18       Impact factor: 5.923

7.  Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia.

Authors:  Rajanikant G Krishnamurthy; Marie-Claude Senut; Daniel Zemke; Jiangyong Min; Mark B Frenkel; Eric J Greenberg; Seong-Woon Yu; Nick Ahn; John Goudreau; Mounzer Kassab; Kiran S Panickar; Arshad Majid
Journal:  J Neurosci Res       Date:  2009-08-15       Impact factor: 4.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.